| ³Ô¹ÏºÚÁÏ > Insurance Division > Life and Health > Life & Health Actuarial > HMO Performance Report |
2009 ³Ô¹ÏºÚÁÏ HMO Performance Report |
| Getting Better/Living with Illness |
|
How well does the HMO care for members who are sick?
A comparison of each HMO’s performance to the ³Ô¹ÏºÚÁÏ HMO average shows how effective the HMOs are in working with doctors to care for members who are sick or living with chronic illness.
|
| HMO |
Management of medicine for depression* |
Care after hospitalization for mental illness |
Appropriate medications for asthma (children)
|
Controlling high blood pressure |
| Aetna - HMO/POS |
68 |
80 |
96 |
71 |
| AmeriHealth - HMO/POS |
59 |
72 |
93 |
66 |
| CIGNA - HMO/POS |
66 |
69 |
94 |
64 |
| Health Net - HMO/POS |
67 |
82 |
96 |
71 |
| Horizon - HMO |
66 |
84 |
96 |
71 |
| Oxford - HMO/POS |
62 |
79 |
95 |
59 |
*Antidepressant Medication Management rate is based on Effective Acute Phase Treatment, as Optimal Practitioner Contacts for Medication Management retired this year. |
| |
Management of medicine for depression
People taking medicine for depression need to be monitored. Percent of members given medicine for depression who had follow-up visits: |
|
Care after hospitalization for mental illness
Therapy after a hospital stay for mental illness is important for recovery. Percent of members hospitalized for mental illness who received care afterwards: |
 |
|
 |
| |
|
|
Appropriate medications for asthma (children)
With appropriate therapies, long term control of persistent asthma can be achieved, resulting in a decrease in hospitalizations and emergency room visits for treatment. Percent of pediatric members aged 5–17 with persistent asthma who received an appropriate therapy in the past year: |
|
Controlling high blood pressure
High blood pressure (hypertension) is a major
risk factor for a number of diseases and must be
closely monitored and controlled. Percent of
members aged 18–85 with hypertension whose
blood pressure was under control at their most
recent medical visit: |
 |
|
 |
|
|
